Dr Agarwals Eye Hospital Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Sep 2025 is 15.20% vs 21.52% in Sep 2024

Standalone Net Profit

YoY Growth in quarter ended Sep 2025 is 36.54% vs 12.39% in Sep 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 34.14% vs 28.74% in Sep 2024

Interest

YoY Growth in quarter ended Sep 2025 is 1.63% vs 117.16% in Sep 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Dr Agarwal's Eye With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

117.72

269.78

-152.06

-56.36%

Other Operating Income

0.00

Total Operating income

117.72

269.78

-152.06

-56.36%

Raw Material Cost

0.00

Purchase of Finished goods

11.85

0.00

11.85

(Increase) / Decrease In Stocks

0.07

0.00

0.07

Employee Cost

21.44

38.25

-16.81

-43.95%

Power Cost

0.00

Manufacturing Expenses

27.57

162.86

-135.29

-83.07%

Selling and Distribution Expenses

0.00

Other Expenses

16.71

18.51

-1.80

-9.72%

Total Expenditure (Excl Depreciation)

77.64

219.62

-141.98

-64.65%

Operating Profit (PBDIT) excl Other Income

40.08

50.16

-10.08

-20.10%

Other Income

0.68

7.78

-7.10

-91.26%

Operating Profit (PBDIT)

40.76

57.94

-17.18

-29.65%

Interest

3.73

6.93

-3.20

-46.18%

Exceptional Items

0.00

Gross Profit (PBDT)

37.03

51.01

-13.98

-27.41%

Depreciation

11.31

11.24

0.07

0.62%

Profit Before Tax

25.72

39.77

-14.05

-35.33%

Tax

6.40

9.80

-3.40

-34.69%

Provisions and contingencies

0.00

Profit After Tax

19.32

29.96

-10.64

-35.51%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

19.32

29.96

-10.64

-35.51%

Equity Capital

4.83

13.89

-9.06

-65.23%

Face Value

10.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

40.00

2.16

37.84

1,751.85%

Diluted Earnings per share

41.04

1.89

39.15

2,071.43%

Operating Profit Margin (Excl OI)

34.05%

18.59%

0.00

15.46%

Gross Profit Margin

31.46%

18.91%

0.00

12.55%

PAT Margin

16.41%

11.11%

0.00

5.30%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 117.72 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 0.68% vs 17.12% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 15.20% vs 21.52% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 19.32 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 11.94% vs 7.94% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 36.54% vs 12.39% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 40.08 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 7.95% vs 17.54% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 34.14% vs 28.74% in Sep 2024

Quarterly - Interest

Interest 3.73 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -10.34% vs 43.94% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 1.63% vs 117.16% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 34.05%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024